#USA #Menlo Park, California #MyOme #Proactive Health #Concierge Clinics

MyOme Launches Proactive Health Network

MyOme, a prominent player in clinical whole genome testing, has officially launched a pioneering national platform known as the Proactive Health Network (PHN). This innovative initiative aims to unite top-tier concierge and executive health clinics with a shared objective: to shift the medical paradigm from reactive disease treatment to proactive, personalized health management.

The Proactive Health Network is set to redefine the landscape of healthcare by promoting a model of proactive medicine that emphasizes prevention and personalized care. The network includes distinguished members like SHIFT Life, @well Longevity Institute, Exponential Health, Michiana VIP MD, Longevity Maine, Arlington Medical Associates, and Ms. Medicine, all dedicated to using advanced genomic insights to tailor healthcare strategies.

The Vision Behind PHN

Yasser Ads, MD, Chief Business Officer at MyOme, stated, “The future of medicine is proactive, not reactive.” This vision is central to the PHN, which leverages both genomic and real-world data to fundamentally alter the approach toward preventive care. By combining their expertise, partner clinics aim to harness the power of the genome to create a new standard in patient care and engagement.

What the Network Offers

The MyOme PHN provides clinics with access to cutting-edge whole-genome sequencing technology and a comprehensive suite of insights across various health dimensions, including cardiometabolic, neurodegenerative, oncologic, and pharmacogenomic domains. This unique offering is designed to empower clinics by facilitating seamless integration into their operations without adding operational burdens.

The network is engineered with detailed support in logistics, including digital ordering and secure reporting. This streamlined process enables clinics to deliver high-value genomic care to their patients efficiently.

Participating clinics will benefit from enhanced visibility and marketing opportunities, co-branded assets, and early access to emerging MyOme innovations. Founding members will also be able to access de-identified trends from the network, participate in roundtable discussions, and collaborate on education and research initiatives.

Long-Term Engagement with Patients

A key feature of the PHN is its potential for ongoing patient engagement. The genome is analyzed once but can be reinterpreted as scientific knowledge advances, allowing clinics to continuously provide new insights. This ongoing process strengthens patient relationships and enhances wellness programs, keeping individuals invested in their health over time.

Dr. William H Baer, President and CMO at Exponential Health, expressed enthusiasm about joining the PHN, stating, “This partnership represents a transformative shift toward proactive care.” Their commitment to providing exceptional wellness outcomes mirrors MyOme’s goals, reinforcing the network's impact.

Economic and Clinical Benefits

The PHN's launch not only signifies a new chapter for genomic medicine but also enhances the business model of preventive care. Concierge and executive health practices face increasing expectations for differentiated services and measurable health outcomes. The MyOme network model enables partner clinics to unlock a sustainable precision prevention strategy, ultimately driving economic and clinical benefits.

For these clinics, participation in the PHN can lead to increased patient retention and enhanced perceived value, creating new revenue opportunities. Employers and population health programs can expect to see quantifiable returns on investment through lower healthcare costs, fewer acute medical events, and improved long-term health outcomes.

For patients, this translates to earlier disease detection, individualized preventive measures, and ongoing engagement—an era where health is actively managed rather than passively observed.

Joining the Movement

MyOme is currently inviting leading concierge, executive health, and longevity practices to join this groundbreaking network at no cost. Interested clinics can find more information about participation on MyOme’s website or reach out directly via email.

About MyOme

MyOme, Inc. stands at the forefront of clinical genomics, empowering individuals and healthcare systems to navigate their genetic vulnerabilities effectively. The company utilizes advanced genomics and analytics to provide actionable healthcare insights, ensuring that both individuals and practitioners can better understand genetic risks and craft informed health strategies.

For further details about MyOme and the Proactive Health Network, please visit www.myome.com.